<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Eczema Cured &#187; Eczema / Psoriasis</title>
	<atom:link href="http://eczemacured.com/category/eczema-psoriasis/feed/" rel="self" type="application/rss+xml" />
	<link>http://eczemacured.com</link>
	<description></description>
	<lastBuildDate>Mon, 26 Jul 2010 12:00:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Cellceutix Corporation Selects Destum Partners To Partner Psoriasis Compound</title>
		<link>http://eczemacured.com/253/cellceutix-corporation-selects-destum-partners-to-partner-psoriasis-compound/</link>
		<comments>http://eczemacured.com/253/cellceutix-corporation-selects-destum-partners-to-partner-psoriasis-compound/#comments</comments>
		<pubDate>Mon, 26 Jul 2010 12:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3GzR</guid>
		<description><![CDATA[Cellceutix Corporation (OTCBB: CTIX) is pleased to announce that it has selected Destum Partners to assist in finding a development partner for its psoriasis compound, KM-133. Cellceutix management has carefully evaluated which direction to take in the development of KM-133 and has concluded that this is the best way to create shareholder value...]]></description>
			<content:encoded><![CDATA[Cellceutix Corporation (OTCBB: CTIX) is pleased to announce that it has selected Destum Partners to assist in finding a development partner for its psoriasis compound, KM-133. Cellceutix management has carefully evaluated which direction to take in the development of KM-133 and has concluded that this is the best way to create shareholder value...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/253/cellceutix-corporation-selects-destum-partners-to-partner-psoriasis-compound/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study Of Infections Associated With Eczema</title>
		<link>http://eczemacured.com/252/study-of-infections-associated-with-eczema/</link>
		<comments>http://eczemacured.com/252/study-of-infections-associated-with-eczema/#comments</comments>
		<pubDate>Mon, 26 Jul 2010 07:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3Gxw</guid>
		<description><![CDATA[The National Institute of Allergy and Infections Disease has awarded a five-year $31 million contract to National Jewish Health, which is leading a consortium of academic medical centers seeking to better understand skin infections associated with atopic dermatitis...]]></description>
			<content:encoded><![CDATA[The National Institute of Allergy and Infections Disease has awarded a five-year $31 million contract to National Jewish Health, which is leading a consortium of academic medical centers seeking to better understand skin infections associated with atopic dermatitis...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/252/study-of-infections-associated-with-eczema/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PsoriasisDX Genetic Test For Psoriatic Arthritis Now Available In Europe As A CE Marked In Vitro Diagnostic Medical Device</title>
		<link>http://eczemacured.com/250/psoriasisdx-genetic-test-for-psoriatic-arthritis-now-available-in-europe-as-a-ce-marked-in-vitro-diagnostic-medical-device/</link>
		<comments>http://eczemacured.com/250/psoriasisdx-genetic-test-for-psoriatic-arthritis-now-available-in-europe-as-a-ce-marked-in-vitro-diagnostic-medical-device/#comments</comments>
		<pubDate>Thu, 22 Jul 2010 08:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3Grd</guid>
		<description><![CDATA[Molecular dermatology research and development innovator DermaGenoma, Inc. today announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis (PsA) is now available as a CE Marked product under the European In Vitro Diagnostic Directive.  CE Marking is required for certain product groups to indicate conformity with the essential requirements set out in European Directives...]]></description>
			<content:encoded><![CDATA[Molecular dermatology research and development innovator DermaGenoma, Inc. today announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis (PsA) is now available as a CE Marked product under the European In Vitro Diagnostic Directive.  CE Marking is required for certain product groups to indicate conformity with the essential requirements set out in European Directives...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/250/psoriasisdx-genetic-test-for-psoriatic-arthritis-now-available-in-europe-as-a-ce-marked-in-vitro-diagnostic-medical-device/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Decrease In Pediatric Eczema Following Probiotic Use During Pregnancy And Breast Feeding</title>
		<link>http://eczemacured.com/251/decrease-in-pediatric-eczema-following-probiotic-use-during-pregnancy-and-breast-feeding/</link>
		<comments>http://eczemacured.com/251/decrease-in-pediatric-eczema-following-probiotic-use-during-pregnancy-and-breast-feeding/#comments</comments>
		<pubDate>Thu, 22 Jul 2010 07:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3Gqz</guid>
		<description><![CDATA[Mothers who drank milk with a probiotic supplement during and after pregnancy were able to cut the incidence of eczema in their children by almost half, a new study published in the British Journal of Dermatology has shown...]]></description>
			<content:encoded><![CDATA[Mothers who drank milk with a probiotic supplement during and after pregnancy were able to cut the incidence of eczema in their children by almost half, a new study published in the British Journal of Dermatology has shown...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/251/decrease-in-pediatric-eczema-following-probiotic-use-during-pregnancy-and-breast-feeding/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Enbrel® (etanercept) Recommended In UK For Adults With Active And Progressive Psoriatic Arthritis By NICE</title>
		<link>http://eczemacured.com/246/enbrel%c2%ae-etanercept-recommended-in-uk-for-adults-with-active-and-progressive-psoriatic-arthritis-by-nice/</link>
		<comments>http://eczemacured.com/246/enbrel%c2%ae-etanercept-recommended-in-uk-for-adults-with-active-and-progressive-psoriatic-arthritis-by-nice/#comments</comments>
		<pubDate>Mon, 14 Jun 2010 07:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3DPK</guid>
		<description><![CDATA[NICE (The National Institute for Health and Clinical Excellence) has recommended Enbrel® (etanercept) as a treatment option for adults with active and progressive psoriatic arthritis.  NICE makes recommendations to the NHS (National Health Service) on new and existing medicines, treatments and procedures, and treating and caring for people with specific diseases and conditions...]]></description>
			<content:encoded><![CDATA[NICE (The National Institute for Health and Clinical Excellence) has recommended Enbrel® (etanercept) as a treatment option for adults with active and progressive psoriatic arthritis.  NICE makes recommendations to the NHS (National Health Service) on new and existing medicines, treatments and procedures, and treating and caring for people with specific diseases and conditions...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/246/enbrel%c2%ae-etanercept-recommended-in-uk-for-adults-with-active-and-progressive-psoriatic-arthritis-by-nice/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comment On Research Suggesting Early Introduction Of Fish Decreases The Risk Of Eczema In Infants</title>
		<link>http://eczemacured.com/243/comment-on-research-suggesting-early-introduction-of-fish-decreases-the-risk-of-eczema-in-infants/</link>
		<comments>http://eczemacured.com/243/comment-on-research-suggesting-early-introduction-of-fish-decreases-the-risk-of-eczema-in-infants/#comments</comments>
		<pubDate>Fri, 11 Jun 2010 08:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3DMK</guid>
		<description><![CDATA['There is now a wealth of research indicating that a person's diet can contribute to their risk of developing asthma and allergies, most likely as a result of their antioxidant, lipid and vitamin E intake...]]></description>
			<content:encoded><![CDATA['There is now a wealth of research indicating that a person's diet can contribute to their risk of developing asthma and allergies, most likely as a result of their antioxidant, lipid and vitamin E intake...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/243/comment-on-research-suggesting-early-introduction-of-fish-decreases-the-risk-of-eczema-in-infants/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PhotoMedex Announces Clinical Trial Using The XTRAC Velocity(R) Laser In The Treatment Of Severe Generalized Psoriasis</title>
		<link>http://eczemacured.com/240/photomedex-announces-clinical-trial-using-the-xtrac-velocityr-laser-in-the-treatment-of-severe-generalized-psoriasis/</link>
		<comments>http://eczemacured.com/240/photomedex-announces-clinical-trial-using-the-xtrac-velocityr-laser-in-the-treatment-of-severe-generalized-psoriasis/#comments</comments>
		<pubDate>Wed, 09 Jun 2010 10:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3DGW</guid>
		<description><![CDATA[PhotoMedex, Inc. (Nasdaq: PHMD) announced that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC Velocity® excimer laser in the treatment of generalized psoriasis when used in combination with Clobex® spray. Dr...]]></description>
			<content:encoded><![CDATA[PhotoMedex, Inc. (Nasdaq: PHMD) announced that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC Velocity® excimer laser in the treatment of generalized psoriasis when used in combination with Clobex® spray. Dr...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/240/photomedex-announces-clinical-trial-using-the-xtrac-velocityr-laser-in-the-treatment-of-severe-generalized-psoriasis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Can-Fite BioPharma Announces Opening Of CF101 Dermatology IND With Phase 2/3 Psoriasis Protocol</title>
		<link>http://eczemacured.com/239/can-fite-biopharma-announces-opening-of-cf101-dermatology-ind-with-phase-23-psoriasis-protocol/</link>
		<comments>http://eczemacured.com/239/can-fite-biopharma-announces-opening-of-cf101-dermatology-ind-with-phase-23-psoriasis-protocol/#comments</comments>
		<pubDate>Wed, 09 Jun 2010 08:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3DGc</guid>
		<description><![CDATA[Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite...]]></description>
			<content:encoded><![CDATA[Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/239/can-fite-biopharma-announces-opening-of-cf101-dermatology-ind-with-phase-23-psoriasis-protocol/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STELARA™ Significantly Improves Symptoms Of Depression, Anxiety And Health-Related Quality Of Life In Patients With Moderate To Severe Psoriasis</title>
		<link>http://eczemacured.com/233/stelara%e2%84%a2-significantly-improves-symptoms-of-depression-anxiety-and-health-related-quality-of-life-in-patients-with-moderate-to-severe-psoriasis/</link>
		<comments>http://eczemacured.com/233/stelara%e2%84%a2-significantly-improves-symptoms-of-depression-anxiety-and-health-related-quality-of-life-in-patients-with-moderate-to-severe-psoriasis/#comments</comments>
		<pubDate>Thu, 20 May 2010 17:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3CT6</guid>
		<description><![CDATA[New research published online in the Journal of the American Academy of Dermatology (JAAD) shows that treatment with STELARA(TM)(Black Triangle Drug) (ustekinumab) significantly improves symptoms of depression, anxiety and health-related quality of life in patients with moderate to severe psoriasis compared to placebo...]]></description>
			<content:encoded><![CDATA[New research published online in the Journal of the American Academy of Dermatology (JAAD) shows that treatment with STELARA(TM)(Black Triangle Drug) (ustekinumab) significantly improves symptoms of depression, anxiety and health-related quality of life in patients with moderate to severe psoriasis compared to placebo...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/233/stelara%e2%84%a2-significantly-improves-symptoms-of-depression-anxiety-and-health-related-quality-of-life-in-patients-with-moderate-to-severe-psoriasis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hopeless Parents Find Relief For Their Children&#8217;s Eczema With Vidazorb(R) Belly Boost™</title>
		<link>http://eczemacured.com/231/hopeless-parents-find-relief-for-their-childrens-eczema-with-vidazorbr-belly-boost%e2%84%a2/</link>
		<comments>http://eczemacured.com/231/hopeless-parents-find-relief-for-their-childrens-eczema-with-vidazorbr-belly-boost%e2%84%a2/#comments</comments>
		<pubDate>Tue, 18 May 2010 18:00:00 +0000</pubDate>
		<dc:creator>Eczema / Psoriasis News From Medical News Today</dc:creator>
				<category><![CDATA[Eczema / Psoriasis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3CM4</guid>
		<description><![CDATA[May is National Asthma and Allergy Awareness Month and, though many parents deal with their kids' allergies year-round, it's a time for education on the subject. One allergic reaction to food, fabric, grass, pollen, environmental factors, etc. is eczema, which recent statistics show develops in one out of ten children before the age of five...]]></description>
			<content:encoded><![CDATA[May is National Asthma and Allergy Awareness Month and, though many parents deal with their kids' allergies year-round, it's a time for education on the subject. One allergic reaction to food, fabric, grass, pollen, environmental factors, etc. is eczema, which recent statistics show develops in one out of ten children before the age of five...]]></content:encoded>
			<wfw:commentRss>http://eczemacured.com/231/hopeless-parents-find-relief-for-their-childrens-eczema-with-vidazorbr-belly-boost%e2%84%a2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
